Concepedia

Victor Tam

VT

Statistics

Publications

6

Citations

669

H-Index

6

Active since

2009

Affiliations

MannKind Corporation (United States)(Current)

Victor Tam is an author at MannKind Corporation (United States) specializing in medicine, immunology, and cancer vaccines.

Top concepts

Publications per year

2009–2014

6

Publications

6

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 431 citations · Full text

Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors

Mário Sanches, Nicole M. Duffy, Manisha Talukdar et al. · Nature Communications · 2014 · 130 citations · Full text

, , +9

Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors

Brenna L. Meisenburg, Victor Tam, Robb R. Pagarigan et al. · Clinical Cancer Research · 2009 · 38 citations · Full text

Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides

Victor Tam, Raymond M.H. Wong, Robb R. Pagarigan et al. · Vaccine · 2009 · 33 citations

, , +10

TLR-9 signaling and TCR stimulation co-regulate CD8+ T cell-associated PD-1 expression

Raymond M.H. Wong, Victor Tam, Robb R. Pagarigan et al. · Immunology Letters · 2009 · 26 citations

, , +9

1–5 of 6